You are not allowing for the future growth of value of MCL which will be at much higher rate than the Bauxite business. It might have been only a choice between an IPO for MCL or QBL making an offer to buy the remaining 45%. Staying with the status quo might have been an impractical option, as there is much more to this than was in the Ann. The directors' interests are aligned with those of the SHs, but magnified. I would think there was little or no selling of shares of the top 20 holders, this week. Probably around 10% of shares changed hands.
- Forums
- ASX - By Stock
- Ann: Q&A on the merger of QBL MCL and Medcan
You are not allowing for the future growth of value of MCL which...
-
- There are more pages in this discussion • 489 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CGB (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online